Who is sponsoring NCT05554705?

NCT05554705 is sponsored by Blue Cross Blue Shield of Vermont.

What drugs are being tested in NCT05554705?

Interventions in NCT05554705: Intensive Lifestyle intervention.

What condition does NCT05554705 study?

NCT05554705 studies Lifestyle Risk Reduction, Rheumatoid Arthritis.

Is NCT05554705 still recruiting?

NCT05554705 is currently terminated. Last updated 4 August 2023.

Last reviewed 2023-08-04 · How we verify

NCT05554705

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lifestyle Intervention for Rheumatoid Arthritis

Terminated NA Last updated 4 August 2023

What this trial tests

NA trial testing Intensive Lifestyle intervention in Lifestyle Risk Reduction in 114 participants. Terminated before completion.

Timeline

2 January 2023

Primary endpoint
2 January 2023

2 January 2023

Quick facts

Lead sponsor	Blue Cross Blue Shield of Vermont
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	114
Start date	2 January 2023
Primary completion	2 January 2023
Estimated completion	2 January 2023
Sites	1 location across United States

Drugs / interventions tested

Intensive Lifestyle intervention

Conditions studied

Lifestyle Risk Reduction — all drugs for Lifestyle Risk Reduction →
Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →

Sponsor

Blue Cross Blue Shield of Vermont

Who can join

18 and older, any sex, with Lifestyle Risk Reduction or Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this study is to assess whether adding a multifaceted lifestyle intervention to the standard best practice of care can be more effective than standard best practices alone for treating Rheumatoid Arthritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lifestyle Risk Reduction

Currently open trials in the same condition.

NCT07424443 — Pilot Study of a Brain Health Program in Senior Centers · NA · recruiting
NCT06822387 — Health Without Barriers/Salud Sin Barreras- Northern Colorado · NA · recruiting
NCT06424847 — Effects of a Lifestyle and Sleep Intervention in Non-exercising Adults · NA · recruiting
NCT06420817 — Effect of a Customised Lifestyle Medicine Strategy on Lowering Blood Lipid Levels in Indian Physicians · NA · active not recruiting
NCT04932928 — Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05554705 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Blue Cross Blue Shield of Vermont
Last refreshed: 4 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05554705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing